A Study of Two Different Formulations of 611 in Healthy Adult Subjects in China

Phase 1 Not yet recruiting 180 enrolled Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

RandomizedParallel-groupOpen-labelTreatment

Summary

The main purpose of this study is to compare two different formulations (mixtures) of 611 in healthy participants. This study will compare how much of each formulation gets into the blood stream.

Timeline

Start: 2025-07
Primary completion: 2026-01
Completion: 2026-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	611	Monoclonal antibody	300 mg	Subcutaneous

A Study of Two Different Formulations of 611 in Healthy Adult Subjects in China

Summary

Timeline

Drugs

Indications